In endeavoring to fight the increasing occurrences of superbug outbreaks in hospitals, a recent study has advocated for the extension of patient screening processes, encompassing all patients regardless of their perceived risk levels. This novel study was functionally orchestrated by a team of researchers from the Mount Sinai Brooklyn Hospital, USA. The research objective was to assess and juxtapose patient screening results and outcomes both pre and post broadened screening methodology adoption. This methodology involves a divergence from previous practice by screening all patients as opposed to previously prioritized high-risk individuals.
The cornerstone of this study was the investigative review of screening protocols for Candida auris, an infamously hazardous and frequently drug-resistant fungal pathogen easily transmitted within hospital spaces. Candida auris was initially discovered in 2009 and has since proliferated globally, posing a significant challenge to healthcare provision.
Published results in the American Journal for Infection Control suggest that extending the scope of patient screening bolsters early case detection. This widens the venire for infection prevention and creates an impetus for the control teams to isolate cases in the preliminary stages before contamination of hospital equipment or infection transmission to other patients can materialize.
Expanding this screening nonetheless is met with challenges as the process is resource-demanding and may not be practically feasible in healthcare settings where patient isolation is problematic whilst awaiting test results. ‘The early identification of patients possessing C. auris bolsters our ability to safeguard other patients and curbs further pathogen spread within the hospital locale and shared equipment,’ stated Scott Lorin, the President of Mount Sinai Brooklyn. He further added that ‘taking into account the number of individuals a patient interacts with throughout their hospital stay, countless patients are now safer courtesy of this broader screening implementation.’
This groundbreaking study was actually inspired by the case of one patient admitted to Mount Sinai in 2022. This patient, only diagnosed with a C. auris after over two-months in the hospital, was initially not screened for this pathogen due to being classified as low-risk. Following diagnosis, a comprehensive outbreak investigation was triggered, examining 118 individuals who either directly interacted with the patient or utilized the same hospital equipment. This exploration led to the identification of eight more patients who tested positive for C. auris.
In summation, Scott Lorin asserts that expanded screening qualifies as such an effective measure in infection prevention, that all hospitals should consider integrating it into their standard practices. This is invaluable advice, especially for regions grappling with a circulating presence of this pathogen.